Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Phase III, Prospective, Randomized, Double-blind, Multicenter, National, Comparative Between Oxybutynin Chloride With Placebo to Evaluate the Efficacy and Safety for Systemic Treatment of Primary Hyperhidrosis.

NCT02099695 is registered in ClinicalTrials.gov with Cristália Produtos Químicos Farmacêuticos Ltda. as lead sponsor.

NCT NCT02099695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02099695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Phase III, Prospective, Randomized, Double-blind, Multicenter, National, Comparative Between Oxybutynin Chloride With Placebo to Evaluate the Efficacy and Safety for Systemic Treatment of Primary Hyperhidrosis.
Lead sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2015
Completion date
February 29, 2016
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhidrosis